Endometrin Insert
FDA Label NDC 55566-6500

24 label sections · Submitted to the FDA by Ferring Pharmaceuticals Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Ferring Pharmaceuticals Inc. for the product Endometrin (NDC 55566-6500). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2 dosage and administration, 3 dosage forms and strengths, 4 contraindications, 5.1 cardiovascular or cerebrovascular disorders, 5.2 depression, 6.1 clinical studies experience, 7 drug interactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.